Fracture Risk Assessment in the 2023 Osteoporosis Canada Guideline.

Area of Science:

• Radiology
• Osteoporosis Management
• Bone Health

Background:

• Osteoporosis is a common condition characterized by reduced bone strength and increased fracture risk.
• Diagnostic imaging specialists, particularly radiologists, are crucial in managing osteoporosis.
• Bone mineral density (BMD) measurement via dual-energy X-ray absorptiometry (DXA) is key for identifying high-risk individuals.

Purpose of the Study:

• To familiarize radiologists and diagnostic imaging specialists with reporting requirements for the 2023 Osteoporosis Canada clinical practice guideline.
• To guide the implementation of the FRAX™ risk calculation tool in radiology workflows.
• To support evidence-based fracture prevention strategies through accurate reporting.

Main Methods:

• Review of the 2023 Osteoporosis Canada clinical practice guideline.
• Explanation of treatment recommendations based on fracture history, 10-year major osteoporotic fracture (MOF) risk, and BMD T-score.
• Guidance on integrating the FRAX™ tool into existing radiology reporting practices.

Main Results:

• The 2023 guideline integrates fracture history, MOF risk, and BMD T-score for treatment recommendations.
• The FRAX™ tool provides a standardized method for calculating 10-year MOF risk.
• Transitioning from the Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool to FRAX™ is feasible within current radiology workflows.

Conclusions:

• Radiologists' accurate reporting is essential for implementing updated osteoporosis guidelines.
• Utilizing the FRAX™ tool facilitates standardized fracture risk assessment.
• Seamless integration of FRAX™ reporting supports effective osteoporosis management and fracture prevention.